Neuroscience

New Huntington's treatment prevents protein aggregation

Scientists at Northwestern and Case Western Reserve universities have developed the first polymer-based therapeutic for Huntington's disease, an incurable, debilitating illness that causes nerve cells to break down in the ...

Parkinson's & Movement disorders

Study reveals racial disparities in Huntington's disease diagnoses

Research led by UCLA Health reveals that Black patients with Huntington's disease in the U.S. and Canada received their diagnoses, on average, one year later compared to white patients after symptoms first appear.

page 2 from 18